AstraZeneca coronavirus vaccine clinical trials resume in U.K. after pause over safety concerns
AstraZeneca’s building in Luton, Britain.
Tim Ireland | Xinhua News Agency | Getty Images
Phase three trials for AstraZeneca’s coronavirus vaccine have resumed in the U.K. after they were halted earlier this week over safety concerns, raising hope that one of the leading candidates in the global race to develop an injection which can stem the pandemic is back on track.
AstraZeneca said it received confirmation from the United Kingdom’s Medicines Health Regulatory Authority that it was safe to resume clinical trials. The company declined to disclose medical information about the pause of the trial, but indicated earlier this week that a potentially unexplained illness was under investigation.
The company said “the standard review process triggered a voluntary pause” to all global trials on Sept. 6 so that independent committees and internal regulators could review the safety data. While trials …continued .
[Source: CNBC News]